FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like Another Day, Another Breakthrough Tag for GlaxoSmithKline's Bexsero February 6, 2018 Ironwood Provides First Quarter 2017 Investor Update May 7, 2017 Biogen's Early-Stage Alzheimer's Data Continues to Impress November 1, 2017
